Cardiovascular
CILMODEV M
| Specification | Details |
|---|---|
| Generic Name | Cilnidipine + Metoprolol Succinate |
| Strength | Cilnidipine IP 10 mg + Metoprolol Succinate IP 23.75 mg equivalent to Metoprolol Tartrate IP 25 mg, Extended Release |
| Dosage Form | Tablet |
| Pack Size | 10 Tablets |
| Standard | Flunarizine Tablets IP — Flunarizine Tablets are included as an Indian Pharmacopoeia monograph |
| Shelf Life | 24 months from the date of manufacture |
| Storage | Store below 30°C. Protect from direct sunlight |
| Regulatory Status | Schedule H · Valid prescription required. |
Product Highlights
- Dual-action antihypertensive combination containing a calcium-channel blocker and beta-blocker.
- Cilnidipine blocks L-type and N-type calcium channels, helping relax blood vessels and reduce peripheral vascular resistance.
- Metoprolol Succinate is a selective beta-1 blocker that helps reduce heart rate and cardiac workload.
- Provides complementary mechanisms for effective blood-pressure control.
- Extended-release Metoprolol supports sustained antihypertensive action.
- Used when adequate blood-pressure control requires combination therapy
Indications
-
- Hypertension / High Blood Pressure
- Hypertension requiring combination antihypertensive therapy





